Investment
Features
FeesSafety
Academy
More
Pluang+

Compare The Magnum Ice Cream Company N.V. Ordinary Shares (MICC) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance

The Magnum Ice Cream Company N.V. Ordinary SharesTrade
State Street SPDR S&P Biotech ETFTrade

Price performance (Past 24H)

Key statistics

The Magnum Ice Cream Company N.V. Ordinary Shares vs State Street SPDR S&P Biotech ETF — how do they compare? The Magnum Ice Cream Company N.V. Ordinary Shares trades at $18.49 (market cap $10.72B), while State Street SPDR S&P Biotech ETF trades at $147.19 (market cap $10.27B). The key difference: The Magnum Ice Cream Company N.V. Ordinary Shares and State Street SPDR S&P Biotech ETF are close in size by market cap, and State Street SPDR S&P Biotech ETF is more actively traded (9,751,587 versus 1,309,650). Which is the better fit depends on your goals — on Pluang, investors hold The Magnum Ice Cream Company N.V. Ordinary Shares for 0 Days and State Street SPDR S&P Biotech ETF for 39 Days on average.

MICCXBI
Market Cap
$10.72B$10.27B
Volume
1,309,6509,751,587
Sector
Consumer StaplesBroad Market / Factor
52-Week High
$20.42$169.55
52-Week Low
$13.06$107.32
Typical Hold Time
0 Days39 Days
Enterprise Value
$14.14B—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

The Magnum Ice Cream Company N.V. Ordinary Shares

No Aura AI signal available yet.

State Street SPDR S&P Biotech ETF

XBI trades at $146.8, down 3.04% today, with a bearish technical signal driven by selling pressure in moving averages. The ETF's modified equal-weight structure provides exposure to over 150 biotech companies, benefiting from M&A activity and positive clinical catalysts. Recent news highlights sector optimism from cancer vaccine breakthroughs and improved capital access, though the ETF carries higher volatility than diversified healthcare funds.

Outlook remains mixed with neutral analyst consensus but positive sector catalysts. Opportunities include biotech innovation and M&A potential, while risks involve high volatility, regulatory uncertainty, and expense ratios above broader healthcare ETFs. Investors should weigh targeted biotech exposure against sector-wide stability.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MICC
100% Buy0% Sell
Avg holding period · 0 Days
XBI
100% Buy0% Sell
Avg holding period · 39 Days

About The Magnum Ice Cream Company N.V. Ordinary Shares

The Magnum Ice Cream Company N.V. manufactures and sells ice cream and frozen desserts through brands including Magnum, Ben & Jerry's, Wall's, and Cornetto, distributing across roughly 80 countries.

Read more on MICC →

About State Street SPDR S&P Biotech ETF

XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.

Read more on XBI →